Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Hace 2 días · Jiang Zemin →. Deng Xiaoping ( Chinese: 邓小平 [a]; 22 August 1904 – 19 February 1997) was a Chinese revolutionary and statesman who served as the paramount leader of the People's Republic of China (PRC) from December 1978 to November 1989.

  2. 17 de may. de 2024 · University Innovation Fellows Candidate

  3. www.forbes.com › profile › zhang-bangxinZhang Bangxin - Forbes

    Hace 2 días · Zhang Bangxin. $2.4B. $32M (1.35%) Real Time Net Worth. as of 5/30/24. #1417 in the world today. Photo by ImagineChina. About Zhang Bangxin. Zhang Bangxin is the cofounder and...

  4. Hace 3 días · Although the issue of embodied pollutants in China's supply chains has garnered increasing attention, the dynamic changes occurring within them are unclear. Several existing studies analyze one-year or short-term data in supply chain. China's overall CH4 emissions have risen from 41.1 Tg in 2000 to 60 Tg in 2020, so conducting long-term analyses can yield a deeper understanding of the dynamic ...

  5. 14 de may. de 2024 · BBC News. 14 May 2024. The whereabouts of a Chinese citizen journalist jailed for covering the early days of the Covid-19 pandemic is still unknown a day after she was expected to have been ...

  6. www.lanxin.cnLanXin

    16 de may. de 2024 · 蓝信新闻. 2024-01-02 数据泄露屡见不鲜 协同办公安全为先. 2024-05-16 蓝信获首批国家涉密信息系统产品检测证书. 2024-03-21 2023→2024,十大关键词开启蓝信新征程. 2024-01-29 打造铁路行业专属协同应急平台,蓝信助力铁路局应对春运挑战. 2024-01-15 《2023年央 ...

  7. Hace 2 días · Purpose EGFR classical mutations respond well to EGFR tyrosine kinase inhibitors. However, it is uncertain whether currently available EGFR-TKIs are effective against rare EGFR mutations and compound mutations. Herein, the effectiveness of almonertinib and alflutinib, the third-generation tyrosine kinase inhibitors developed in China, on rare EGFR S768I mutations and compound mutations is ...